Share on StockTwits
 

Stock analysts at Cowen and Company hoisted their price target on shares of Zimmer Holdings (NYSE:ZMH) from $84.00 to $96.00 in a report issued on Friday, American Banking News.com reports. Cowen and Company’s price objective would suggest a potential upside of 3.18% from the stock’s previous close.

Several other analysts have also recently commented on the stock. Analysts at Brean Capital raised their price target on shares of Zimmer Holdings from $90.00 to $111.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Separately, analysts at Argus raised their price target on shares of Zimmer Holdings from $98.00 to $110.00 in a research note to investors on Thursday, January 16th. They now have a “buy” rating on the stock. Finally, analysts at Barclays raised their price target on shares of Zimmer Holdings from $100.00 to $110.00 in a research note to investors on Thursday, January 9th. They now have an “overweight” rating on the stock. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $93.48.

Zimmer Holdings (NYSE:ZMH) traded up 0.16% during mid-day trading on Friday, hitting $93.19. The stock had a trading volume of 211,057 shares. Zimmer Holdings has a 52 week low of $72.24 and a 52 week high of $97.86. The stock has a 50-day moving average of $93.9 and a 200-day moving average of $87.08. The company has a market cap of $15.934 billion and a P/E ratio of 23.58.

Zimmer Holdings (NYSE:ZMH) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.62 by $0.26. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. Analysts expect that Zimmer Holdings will post $5.71 EPS for the current fiscal year.

Zimmer Holdings, Inc (NYSE:ZMH) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.